Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Arena
Arena
Acceleron’s post-Reblozyl plan comes together
EP Vantage
Tue, 01/28/20 - 11:09 am
Acceleron
sotatercept
PAH
JNJ
Bellerophon Therapeutics
United Therapeutics
Vivus
Arena
Novartis
Arena: Belviq Advertising Slips - Sales Continue To Slip As Well
Seeking Alpha
Fri, 09/4/15 - 10:26 am
Arena
Belviq
obesity
drug ads
Arena: Belviq Sales Flattening Out - Is It Sector Saturation?
Seeking Alpha
Wed, 05/20/15 - 10:31 am
Arena
Belviq
obesity
Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus
TheStreet.com
Sat, 02/21/15 - 09:44 am
obesity
Orexigen
Arena
Vivus
Belviq
Contrave
Qsymia
3 Pharma Companies Fighting Obesity
Yahoo/Benzinga
Thu, 10/30/14 - 05:33 pm
obesity
Orexigen
Arena
Vivus
The Future of Fat Fighting: Next-Gen Obesity Drugs
Motley Fool
Sun, 05/25/14 - 10:30 am
obesity
weight loss
Zafgen
beloranid
Arena
Vivus
Qsymia
Belviq
Arena Sees Growth Continue With Belviq
Seeking Alpha
Sat, 03/8/14 - 10:28 am
Arena
Belviq
This Week in Biotech
Motley Fool
Sun, 11/10/13 - 12:56 pm
Keryx
Geron
Arena
Eisai
Vivus
Curis
Immunogen
Arena's Belviq Sales Pass 4,000 On IMS
Seeking Alpha
Sat, 10/5/13 - 09:29 am
Arena
Belviq
obesity
weight loss
Arena Week 11 Sales Up Big
Seeking Alpha
Sat, 08/31/13 - 10:28 am
Arena
Trade-Ideas: Arena Pharmaceuticals (ARNA) Is Today's "Dead Cat Bounce" Stock
The Street
Sat, 08/31/13 - 10:27 am
Arena
Why This Obesity Drug Is the Sector's Best Bet
Motley Fool
Fri, 05/24/13 - 10:49 am
Arena
Belviq
obesity
weight loss
An Obesity Drugmaker's Critical Coming Weeks
Motley Fool
Sun, 04/14/13 - 12:14 pm
Arena
Qsymia
obesity
weight loss
It's Now Time For Vivus Investors To Watch Arena Numbers
Seeking Alpha
Thu, 02/28/13 - 11:28 am
Vivus
Arena
Arena's Marketing Partner Eisai Pharma Seeks Expedited Final Ruling From DEA To Begin Belviq Sales
Seeking Alpha
Mon, 12/24/12 - 10:37 am
Arena
Eisai
Belviq
The Looming EU Approval Makes Arena Pharmaceuticals Significantly Undervalued
Motley Fool
Sun, 12/16/12 - 10:18 am
Arena
Belviq
obesity
weight loss
This Week in Biotech
Motley Fool
Sun, 11/25/12 - 11:15 am
Arena
Vivus
Regeneron
Sanofi
MAP Pharmaceuticals
Allergan
Good News for Vivus and Arena
Motley Fool
Sat, 11/24/12 - 11:37 am
Vivus
Arena
weight loss
obesity
Science Arena Investors Need to Know
Motley Fool
Sat, 09/22/12 - 02:19 pm
Arena
weight loss
obesity
Belviq
Arena And Vivus Set To Dominate The Obesity Drug Market
Seeking Alpha
Thu, 08/30/12 - 09:58 am
Arena
Vivus
obesity
Belviq
Qsymia
Pages
1
2
3
next ›
last »